Recent advances in targeted proteomics for clinical applications.
about
Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass SpectrometryAdvances in targeted proteomics and applications to biomedical researchTargeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study.Taking the stock of granule cargo: Platelet releasate proteomics.Clinical applications of MS-based protein quantification.Psychiatric disorders biochemical pathways unraveled by human brain proteomics.Building proteomic tool boxes to monitor MHC class I and class II peptides.A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization.Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins.Deep-Dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues.Identification of Borrelia protein candidates in mouse skin for potential diagnosis of disseminated Lyme borreliosis.Mass Spectrometry-Based Identification of Extracellular Domains of Cell Surface N-Glycoproteins: Defining the Accessible Surfaceome for Immunophenotyping Stem Cells and Their Derivatives.Advances in endometrial cancer protein biomarkers for use in the clinic.Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
P2860
Q26775066-91D5996D-14CA-4F2D-9979-E0EFB8498DD1Q28066912-4DAA8F24-E90C-4B16-A992-1AE66A7AE166Q36745091-A0A26EBB-4283-4A56-B572-F6A1322489E3Q37651691-75B29B0A-ECC0-4E08-A82C-AEE286901FF8Q38628086-AE9429B3-2096-4CC0-9F8C-FBEE280A0DC4Q38785881-9C3AFDBF-A39D-4873-BB77-46B45C3A3A69Q38802991-1376FBEE-7F3E-42AE-BEE5-719A8734B255Q38885740-21A9422A-D6FA-41DB-980C-8B315D84F8A7Q39032610-E520B1EB-BBFC-4934-9E2B-EE90F6780EA5Q39033381-C4D3DD59-FF0F-440C-A648-B822BF80A046Q39174515-69C868BB-E16A-4F67-8325-9935EEF3B263Q42279966-AA45DD43-ABD0-4088-916A-96C3074071F8Q47097911-5490BF44-2F6C-46AA-93E8-7FC68B15639CQ47267449-26DCB605-74DC-43B0-90B6-5DFBF00E53A1Q47355920-27108ACA-F610-4150-A9DD-C88C2B76684FQ47429427-3D96F69F-A019-425E-BF45-6E8FF2AF7745Q51210845-6FCDC3DE-9E03-497B-9E41-43A191A67DA5
P2860
Recent advances in targeted proteomics for clinical applications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Recent advances in targeted proteomics for clinical applications.
@en
type
label
Recent advances in targeted proteomics for clinical applications.
@en
prefLabel
Recent advances in targeted proteomics for clinical applications.
@en
P2860
P356
P1476
Recent advances in targeted proteomics for clinical applications.
@en
P2093
Bruno Domon
Sebastien Gallien
P2860
P304
P356
10.1002/PRCA.201400136
P577
2015-02-19T00:00:00Z